Two separate mechanisms of enforced viral replication balance innate and adaptive immune activation

Journal of Autoimmunity

Volumn 67, Issue , 2016, Pages 82-89

  Shaabani, Namir ^a,b   Khairnar, Vishal ^a   Duhan, Vikas ^a   Zhou, Fan ^a   Tur, Rita Ferrer ^a   Häussinger, Dieter ^b   Recher, Mike ^c   Tumanov, Alexei V ^d   Hardt, Cornelia ^a   Pinschewer, Daniel ^e   Christen, Urs ^f   Lang, Philipp A ^b   Honke, Nadine ^a,b   Lang, Karl S ^a,b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d TRUDEAU INSTITUTE   (United States)

^e UNIVERSITY OF BASEL   (Switzerland)

^f GOETHE UNIVERSITY   (Germany)

Author keywords

Enforced viral replication; Immunopathology; Lymphocytic choriomeningitis virus (LCMV)

Indexed keywords

INTERFERON; LYMPHOTOXIN BETA; VIRUS VECTOR; UBIQUITIN THIOLESTERASE; USP18 PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; IMMUNE ACTIVATION; IMMUNOLOGICAL PARAMETERS; INNATE IMMUNITY; INOCULATION; INTERFERON PRODUCTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; VIRUS REPLICATION; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPH NODE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS; MACROPHAGE; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

ADAPTIVE IMMUNITY; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LYMPHOTOXIN-BETA; MACROPHAGES; MICE; MICE, KNOCKOUT; SPLEEN; T-LYMPHOCYTE SUBSETS; UBIQUITIN THIOLESTERASE; VIRUS REPLICATION;

EID: 84957598420     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2015.10.004     Document Type: Article

References (24)

1. Teijaro J.R., Ng C., Lee A.M., Sullivan B.M., Sheehan K.C., Welch M., Schreiber R.D., de la Torre J.C., Oldstone M.B. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 2013, 340:207-211.
2. Wilson E.B., Yamada D.H., Elsaesser H., Herskovitz J., Deng J., Cheng G., Aronow B.J., Karp C.L., Brooks D.G. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 2013, 340:202-207.
3. Ng C.T., Sullivan B.M., Teijaro J.R., Lee A.M., Welch M., Rice S., Sheehan K.C., Schreiber R.D., Oldstone M.B. Blockade of interferon beta, but not interferon alpha, signaling controls persistent viral infection. Cell Host Microbe 2015, 17:653-661.
4. Sullivan B.M., Teijaro J.R., de la Torre J.C., Oldstone M.B. Early virus-host interactions dictate the course of a persistent infection. PLoS Pathog. 2015, 11:e1004588.
5. Lang K.S., Georgiev P., Recher M., Navarini A.A., Bergthaler A., Heikenwalder M., Harris N.L., Junt T., Odermatt B., Clavien P.A., et al. Immunoprivileged status of the liver is controlled by toll-like receptor 3 signaling. J. Clin. Invest. 2006, 116:2456-2463.
6. Rennert P.D., James D., Mackay F., Browning J.L., Hochman P.S. Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity 1998, 9:71-79.
7. McCarthy D.D., Summers-Deluca L., Vu F., Chiu S., Gao Y., Gommerman J.L. The lymphotoxin pathway: beyond lymph node development. Immunol. Res. 2006, 35:41-54.
8. Kabashima K., Banks T.A., Ansel K.M., Lu T.T., Ware C.F., Cyster J.G. Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity 2005, 22:439-450.
9. Futterer A., Mink K., Luz A., Kosco-Vilbois M.H., Pfeffer K. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998, 9:59-70.
10. Moseman E.A., Iannacone M., Bosurgi L., Tonti E., Chevrier N., Tumanov A., Fu Y.X., Hacohen N., von Andrian U.H. B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity. Immunity 2012, 36:415-426.
11. Honke N., Shaabani N., Cadeddu G., Sorg U.R., Zhang D.E., Trilling M., Klingel K., Sauter M., Kandolf R., Gailus N., et al. Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat. Immunol. 2012, 13:51-57.
12. Honke N., Shaabani N., Zhang D.E., Iliakis G., Xu H.C., Haussinger D., Recher M., Lohning M., Lang P.A., Lang K.S. Usp18 driven enforced viral replication in dendritic cells contributes to break of immunological tolerance in autoimmune diabetes. PLoS Pathog. 2013, 9:e1003650.
13. Pircher H., Burki K., Lang R., Hengartner H., Zinkernagel R.M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 1989, 342:559-561.
14. Tumanov A., Kuprash D., Lagarkova M., Grivennikov S., Abe K., Shakhov A., Drutskaya L., Stewart C., Chervonsky A., Nedospasov S. Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues. Immunity 2002, 17:239-250.
15. Lang P.A., Contaldo C., Georgiev P., El-Badry A.M., Recher M., Kurrer M., Cervantes-Barragan L., Ludewig B., Calzascia T., Bolinger B., et al. Aggravation of viral hepatitis by platelet-derived serotonin. Nat. Med. 2008, 14:756-761.
16. + T cell immunity. Nat. Med. 2010, 16:339-345.
17. + T cells from NK cell cytotoxicity. Immunity 2014, 40:949-960.
18. Lang P.A., Recher M., Honke N., Scheu S., Borkens S., Gailus N., Krings C., Meryk A., Kulawik A., Cervantes-Barragan L., et al. Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice. Hepatology 2010, 52:25-32.
19. Scheu S., Dresing P., Locksley R.M. Visualization of IFNbeta production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:20416-20421.
20. Zhou S., Cerny A.M., Zacharia A., Fitzgerald K.A., Kurt-Jones E.A., Finberg R.W. Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus. J. Virol. 2010, 84:9452-9462.
21. Schneider-Schaulies J. Cellular receptors for viruses: links to tropism and pathogenesis. J. Gen. Virol. 2000, 81:1413-1429.
22. Wieland S.F., Takahashi K., Boyd B., Whitten-Bauer C., Ngo N., de la Torre J.C., Chisari F.V. Human plasmacytoid dendritic cells sense lymphocytic choriomeningitis virus-infected cells in vitro. J. Virol. 2014, 88:752-757.
23. Shaabani N., Honke N., Dolff S., Gorg B., Khairnar V., Merches K., Duhan V., Metzger S., Recher M., Barthuber C., et al. IFN-gamma licenses CD11b(+) cells to induce progression of systemic lupus erythematosus. J. Autoimmun. 2015, 62:11-21.
24. Hodge D.L., Berthet C., Coppola V., Kastenmuller W., Buschman M.D., Schaughency P.M., Shirota H., Scarzello A.J., Subleski J.J., Anver M.R., et al. IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice. J. Autoimmun. 2014, 53:33-45.